Amid rising concerns over national security and economic self-reliance, the U.S. Congress has introduced the BIOSECURE Act. Aimed at curbing Chinese influence in the biotechnology sector, this legislation prevents companies with Chinese ties from accessing federal funding. While the Act promises
The call for legislative intervention to overturn the FDA's final rule on the regulation of laboratory-developed tests (LDTs) has intensified. The Association for Diagnostics and Laboratory Medicine (ADLM) has been at the forefront, urging lawmakers to take action against the FDA's new
The Biden administration has taken a remarkable step forward in mental health care by finalizing rules that expand mental health coverage standards in private insurance plans. This bold move aims to address the longstanding disparities between mental and physical health benefits, ensuring millions
The debate over the proposed merger of Union Hospital and Terre Haute Regional Hospital under Indiana’s Certificate of Public Advantage (COPA) law has drawn significant attention. The Federal Trade Commission (FTC) has pointed out several issues with the merger, critiquing potential increases in c
The opioid crisis has left an indelible mark on American society, thrusting numerous stakeholders, particularly drug distributors, into the spotlight. The recent $300 million settlement by McKesson, Cardinal, and Cencora represents one of the latest significant efforts to address the multifaceted
The recent decision by the U.S. Department of Health and Human Services (HHS) to appeal a district court ruling on the use of online tracking technologies in healthcare has sent ripples through the industry. This legal battle pits concerns about patient data privacy against the operational needs of
